近日，国际脑科学计划（International Brain Initiative，IBI）宣布，郑加麟教授正式担任IBI战略指导委员会共同主席，与IBI其他主席携手，共同引领这一全球性科学合作组织迈向新阶段。
The International Brain Initiative (IBI) recently announced Prof. ZHENG Jialin has assumed the role of Co-Chair of its Executive Committee. He will provide shared leadership with the IBI chair, helping to advance this global scientific initiative to its next stage of development.
国际脑科学计划组织（International Brain Initiative，IBI）是由全球主要现有及新兴脑科学研究项目组成的国际联盟。该组织通过整合各国脑科学研究力量，旨在推动全球神经科学领域的协同创新与合作发展。此次任命标志着IBI在推动跨国界脑科学研究、促进全球学术协作方面进入深化发展期，致力于倡导“无国界科学”，整合全球脑计划资源，突破地域与学科壁垒，加速脑科学与神经技术创新。IBI表示，未来将依托全球大型脑科学项目的关键合力，并通过与IBRO（国际脑研究组织）等合作伙伴的紧密联动，开拓前所未有的国际合作机遇，为理解大脑、应对神经疾病及发展前沿技术提供开放协同的国际平台。
The International Brain Initiative is a consortium of major existing and emerging brain research projects worldwide, aimed at advancing coordinated innovation and collaborative development in global neuroscience through cross-border integration of research efforts. This move by IBI marks a further step in strengthening the initiative’s role in advancing cross-border brain science research and international academic collaboration, as it works—guided by the principle of “science without borders”—to integrate global brain research resources, reduce geographic and disciplinary barriers, and accelerate progress in brain science and neurotechnology. IBI noted that, going forward, it will leverage the combined strengths of major large-scale brain science projects globally and work in close coordination with partners such as the International Brain Research Organization (IBRO) to open up unprecedented opportunities for international cooperation. Through these efforts, IBI seeks to provide an open and collaborative international platform for advancing the understanding of the brain, addressing neurological diseases, and developing cutting-edge technologies.
郑加麟，神经病学和再生医学专家，国家重大科学研究计划项目首席科学家，教育部脑衰老相关医药基础创新中心主任，中国神经科学会神经退行性疾病分会主任委员，上海市催化医学前沿研究基地主任，国际脑计划（International Brain Initiative, IBI）战略指导委员会共同主席（中国方代表），国际学术健康中心协会（Association of Academic Health Centers International, AAHCI）指导委员会理事，国家自然科学基金委特邀专家，教育部高等学校基础医学类教学指导委员会委员，教育部临床医学专业认证专家，上海市医学会医学教育副会长。郑加麟教授长期致力于神经系统疾病发病机制与治疗策略研究，尤其致力于小胶质细胞介导的神经炎症致病作用与自体重编程神经干细胞外泌体对神经系统疾病的精准化治疗研究，已在国际重要学术期刊发表研究论著260余篇。积极致力于国际化医学教育体系的建设及国际化交流合作，大力推动以成果为导向（Outcome-Based Education, OBE）的课程体系建设，担任国家级规划教材《互联网+医疗健康》及《神经与精神疾病》副主编。曾获美国内布拉斯加大学Gilmore杰出青年科学家奖和杰出科学家奖、上海市住院医师规范化培训杰出贡献奖、同济大学首届“卓越”研究生导学团队标兵（2020）、同济大学2022年度我心目中的好导师。荣获上海市高等教育优秀教学成果项目二等奖（牵头）及高等教育（研究生）国家级教学成果奖二等奖（参与）。
Prof. ZHENG Jialin, Expert in Neurology and Regenerative Medicine; Chief Scientist of National Major Scientific Research Programs; Director of the Medical and Pharmaceutical Basic Research Innovation Center for Brain Aging and Associated Diseases under the Ministry of Education; Senior Member of the Neurodegenerative Disease Research Subcommittee of the Chinese Neuroscience Society; Director of the Shanghai Frontiers Science Center of Nanocatalytic Medicine; Co-Chair of the International Brain Initiative Executive Committee (China Brain Project Representative); Steering Committee Member of the Association of Academic Health Centers International (AAHCI); Invited Expert for the National Natural Science Foundation of China (NSFC); Member of the Ministry of Education's Education and Instruction Committee; Certified Expert of Clinical Medicine; Vice Chairman of the Medical Education Committee of the Shanghai Medical Association.
As a leading expert in neuroinflammation and stem cell therapy for neurodegenerative diseases such as Alzheimer's and HIV-1 associated dementia, Prof. ZHENG has led numerous NIH-funded and international research projects, particularly in microglia-mediated neuroinflammation and the development of precision therapies using autologous neural stem cell-derived exosomes. He has published more than 260 papers in internationally leading academic journals. As a key proponent of international medical education and exchange, he has fostered strategic partnerships between Chinese institutions and leading universities in the United States and Europe, advancing global collaboration in medical education and research. He has also spearheaded the development of outcome-based education (OBE) system and serves as the Deputy Editor for authoritative national textbooks such as Internet + Healthcare and Neurological and Psychiatric Disorders. His honors include the Joseph P. Gilmore Outstanding Investigator Award and Outstanding Scientist Award from the University of Nebraska, the Outstanding Contribution Award for Standardized Resident Training in Shanghai, Tongji University’s Inaugural Outstanding Graduate Student Mentoring Award in 2020, and Tongji University’s “My Favorite Mentor” award in 2022. He is also a recipient of the Second Prize for Outstanding Teaching Achievement in Higher Education (Shanghai, leader) and the Second Prize for National Teaching Achievement in Higher Education (Graduate level, contributor).
